ATE11048T1 - 2-guanidino-4-heteroarylthiazole und diese enthaltende arzneimittel. - Google Patents

2-guanidino-4-heteroarylthiazole und diese enthaltende arzneimittel.

Info

Publication number
ATE11048T1
ATE11048T1 AT81304724T AT81304724T ATE11048T1 AT E11048 T1 ATE11048 T1 AT E11048T1 AT 81304724 T AT81304724 T AT 81304724T AT 81304724 T AT81304724 T AT 81304724T AT E11048 T1 ATE11048 T1 AT E11048T1
Authority
AT
Austria
Prior art keywords
heteroarylthiazole
guanidino
pharmaceuticals containing
pharmaceuticals
Prior art date
Application number
AT81304724T
Other languages
English (en)
Inventor
John Lawrence Lamattina
Christopher Andrew Lipinski
Original Assignee
Pfizer Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc. filed Critical Pfizer Inc.
Application granted granted Critical
Publication of ATE11048T1 publication Critical patent/ATE11048T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/48—Acylated amino or imino radicals by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof, e.g. carbonylguanidines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT81304724T 1980-10-14 1981-10-12 2-guanidino-4-heteroarylthiazole und diese enthaltende arzneimittel. ATE11048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19623180A 1980-10-14 1980-10-14
US06/293,574 US4374843A (en) 1980-10-14 1981-08-20 2-Guanidino-4-heteroarylthiazoles

Publications (1)

Publication Number Publication Date
ATE11048T1 true ATE11048T1 (de) 1985-01-15

Family

ID=26891753

Family Applications (1)

Application Number Title Priority Date Filing Date
AT81304724T ATE11048T1 (de) 1980-10-14 1981-10-12 2-guanidino-4-heteroarylthiazole und diese enthaltende arzneimittel.

Country Status (28)

Country Link
US (1) US4374843A (de)
EP (1) EP0050458B1 (de)
KR (1) KR850001858B1 (de)
AR (3) AR228675A1 (de)
AT (1) ATE11048T1 (de)
AU (2) AU530589B2 (de)
CA (1) CA1156239A (de)
CS (1) CS231182B2 (de)
DD (4) DD202293A5 (de)
DE (1) DE3168067D1 (de)
DK (1) DK453181A (de)
ES (4) ES8301978A1 (de)
FI (1) FI75821C (de)
GR (1) GR75098B (de)
HK (1) HK52387A (de)
HU (2) HU191895B (de)
IE (1) IE51642B1 (de)
IL (1) IL64035A (de)
KE (1) KE3707A (de)
MY (1) MY8700512A (de)
NO (1) NO159654C (de)
NZ (1) NZ198629A (de)
PH (3) PH17562A (de)
PL (3) PL135331B1 (de)
PT (1) PT73817B (de)
SG (1) SG23487G (de)
SU (1) SU1153829A3 (de)
YU (4) YU42434B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4482723A (en) * 1983-04-11 1984-11-13 Pfizer Inc. Process for preparation of 4-acetyl-2-substituted-imidazoles
US4435396A (en) * 1982-05-10 1984-03-06 Pfizer Inc. Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor
AU542287B2 (en) * 1982-06-17 1985-02-14 Toyama Chemical Co. Ltd. Process for producing 2-(2-aminothiazol-4-yl) glyoxylic acid derivative, it:s salt and intermediates therefor
EP0156644A1 (de) * 1984-04-02 1985-10-02 Pfizer Inc. Verfahren und Zwischenprodukte für 4-Acetylimidazole
US4560690A (en) * 1984-04-30 1985-12-24 Pfizer Inc. 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents
US4567179A (en) * 1984-10-11 1986-01-28 Pfizer, Inc. Antiinflammatory salts of piroxicam
US4632993A (en) * 1984-10-11 1986-12-30 Pfizer Inc. Process for making 2-guanidino-4-(2-methyl-4-imidazolyl) thiazole dihydrobromide
US4591595A (en) * 1984-10-11 1986-05-27 Pfizer Inc. 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
US4814341A (en) * 1986-08-26 1989-03-21 Reiter Lawrence A 2-guanidino-4-(2-furyl) thiazoles as antiulcer agents
EP0259085B1 (de) * 1986-08-29 1991-08-21 Pfizer Inc. 2-Guanidino-4-aryl-thiazole für die Behandlung von peptischen Geschwüren
ATE106884T1 (de) * 1986-10-29 1994-06-15 Pfizer Verfahren zur herstellung von 2-(1-pentyl-3- guanidino)-4-(2-methyl-4-imidazolyl)thiazol und dessen kristallinisches dihydrochlorid-trihydrat.
IL95548A0 (en) * 1989-09-15 1991-06-30 Fujisawa Pharmaceutical Co Thiazole derivatives,processes for the preparation thereof and pharmaceutical composition containing the same
WO1992016526A1 (en) * 1991-03-13 1992-10-01 Fujisawa Pharmaceutical Co., Ltd. Thiazole derivatives
SI0928793T1 (en) * 1998-01-02 2002-10-31 F. Hoffmann-La Roche Ag Thiazole derivatives
CN101287711A (zh) * 2005-08-23 2008-10-15 宇部兴产株式会社 1-取代-5-酰基咪唑化合物的制备方法
US9499533B2 (en) 2012-03-27 2016-11-22 Shionogi & Co., Ltd. Aromatic 5-membered heterocyclic derivative having TRPV4-Inhibiting activity
KR20220119653A (ko) 2019-12-20 2022-08-30 테나야 테라퓨틱스, 인코포레이티드 플루오로알킬-옥사디아졸 및 이의 용도
WO2022034121A1 (en) 2020-08-11 2022-02-17 Université De Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1516777A (fr) * 1966-08-02 1968-02-05 Innothera Lab Sa Dérivés du thiazole ainsi que de la thiazolo [4,5-d] pyridazine et leur préparation
US3519637A (en) * 1966-12-06 1970-07-07 Hoffmann La Roche 1-(4-thiazolylmethyl)nitroimidazole derivatives
BE758146A (fr) * 1969-10-29 1971-04-28 Smith Kline French Lab Derives de l'amidine
US3950353A (en) * 1971-03-09 1976-04-13 Smith Kline & French Laboratories Limited Pharmacologically active thiourea and urea compounds
HU168776B (de) * 1973-11-09 1976-07-28
DE2614189A1 (de) * 1976-04-02 1977-10-20 Hoechst Ag Therapeutisch wirksame ureido- und semicarbazido-derivate des tiazols und verfahren zu ihrer herstellung
NZ186965A (en) * 1977-04-20 1980-02-21 Ici Ltd Guanidino derivatives and pharmaceutical compositions
JPS54132566A (en) * 1978-01-18 1979-10-15 Ici Ltd Guanidine derivative*its manufacture and secretion controlling pharmaceutical composition containing it
EP0014057B1 (de) * 1979-01-18 1985-01-02 Imperial Chemical Industries Plc Guanidin-Derivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4220654A (en) * 1979-06-04 1980-09-02 Merck & Co., Inc. Cyclic imidazole cyanoguanidines
AU518569B2 (en) * 1979-08-07 1981-10-08 Farmos-Yhtyma Oy 4-benzyl- and 4-benzoyl imidazole derivatives

Also Published As

Publication number Publication date
DD207718A5 (de) 1984-03-14
ES506216A0 (es) 1982-12-16
DK453181A (da) 1982-04-15
ES8306750A1 (es) 1983-06-01
US4374843A (en) 1983-02-22
YU42434B (en) 1988-08-31
PH17856A (en) 1985-01-09
ES8306751A1 (es) 1983-06-01
IL64035A (en) 1986-01-31
YU105383A (en) 1983-10-31
IE812384L (en) 1982-04-14
YU105183A (en) 1983-10-31
AR228675A1 (es) 1983-03-30
CS750081A2 (en) 1984-02-13
FI813177L (fi) 1982-04-15
KR850001858B1 (ko) 1985-12-28
DE3168067D1 (en) 1985-02-14
PL133712B1 (en) 1985-06-29
DD207719A5 (de) 1984-03-14
PL241643A1 (en) 1983-11-21
NO813442L (no) 1982-04-15
HK52387A (en) 1987-07-17
SU1153829A3 (ru) 1985-04-30
PH17562A (en) 1984-10-01
AU530589B2 (en) 1983-07-21
CA1156239A (en) 1983-11-01
AR228674A1 (es) 1983-03-30
AR229703A1 (es) 1983-10-31
ES8301978A1 (es) 1982-12-16
PL233430A1 (en) 1983-11-21
ES8306749A1 (es) 1983-06-01
CS231182B2 (en) 1984-10-15
GR75098B (de) 1984-07-13
DD202293A5 (de) 1983-09-07
SG23487G (en) 1987-07-10
AU7628781A (en) 1982-04-22
YU42078B (en) 1988-04-30
NZ198629A (en) 1985-02-28
NO159654C (no) 1989-01-25
PT73817B (en) 1983-11-07
PL241644A1 (en) 1983-11-21
FI75821B (fi) 1988-04-29
YU105283A (en) 1983-10-31
MY8700512A (en) 1987-12-31
YU246481A (en) 1983-10-31
AU548992B2 (en) 1986-01-09
HU186788B (en) 1985-09-30
ES515157A0 (es) 1983-06-01
IE51642B1 (en) 1987-01-21
DD207913A5 (de) 1984-03-21
PL134491B1 (en) 1985-08-31
NO159654B (no) 1988-10-17
IL64035A0 (en) 1982-01-31
EP0050458B1 (de) 1985-01-02
ES515158A0 (es) 1983-06-01
FI75821C (fi) 1988-08-08
KR830007638A (ko) 1983-11-04
ES515159A0 (es) 1983-06-01
YU42076B (en) 1988-04-30
YU42077B (en) 1988-04-30
EP0050458A2 (de) 1982-04-28
EP0050458A3 (en) 1982-09-01
PT73817A (en) 1981-11-01
PH18467A (en) 1985-07-18
KE3707A (en) 1987-04-03
AU3206284A (en) 1984-11-29
PL135331B1 (en) 1985-10-31
HU191895B (en) 1987-04-28

Similar Documents

Publication Publication Date Title
ATE24490T1 (de) Phenyl-1-piperidino-2-propanol-derivate, ihre herstellung und diese enthaltende arzneimittel.
DE3676248D1 (de) Ubidecarenon enthaltende arzneimittel.
MX9203117A (es) Benzotiofenos antiestrogenicos y antiandrogenicos.
FI822813A7 (fi) Uudet farmaseuttiset seokset.
DE3580304D1 (de) Arzneimittel.
DE3576276D1 (de) Phenothiazine enthaltende arzneimittel.
NO157525C (no) Katalysator og anvendelse av katalysatoren.
ATE13298T1 (de) Azepinderivate, ihre herstellung und diese enthaltende arzneimittel.
IT8119360A0 (it) 17alfa-acilossi-5beta-corticoidi e 17alfa-acilossi-5alfa-corticoidi.
NL7902726A (nl) Sulfonato-organosilanolverbindingen en preparaten, welke deze bevatten.
ATE15372T1 (de) Hexahydro-trans-und tetrahydropyridoindolderivate und diese enthaltende neuroleptische mittel.
FI852658A7 (fi) Farmaseuttiset aineet.
TR20873A (tr) Asiluereler,bu bilesimleri ihtiva eden hasere oeldueruecue maddeler ve bu maddelerin imaline mahsus islemler
IT8125692A0 (it) 5alfa-androstan-17beta-carbossilati e 5beta-androstan-17beta-carbossilati .
DE3683815D1 (de) Organozinnverbindungen und diese enthaltende pestizide.
IT8119652A0 (it) Fenossiisobutirrati di moroxidina e medicamenti contenenti gli stessi.
NO811003L (no) Farmasoeytiske preparater.
NL189488C (nl) Geplooide en gecompacteerde voedselomhulling.
FI811880A7 (fi) Farmaseuttisia bisyklisiä yhdisteitä ja seoksia.
IT8123659A0 (it) Composizioni farmaceutiche contenenti amitriptilina.
MX9203174A (es) Composicion farmaceutica con actividad antiflogistica antipirectica y antalgica.
DE3580263D1 (de) 1-oxa-1-dethia-cephalosporinverbindungen und sie enthaltendes antibakterielles arzneimittel.
DE3677616D1 (de) 2-azolylpropionatderivate und diese enthaltende fungizide.
ATE19815T1 (de) Stopfbuchse und packungen.
ATE50581T1 (de) Neue phosphorverbindungen und diese enthaltende arzneimittel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee